|
|
|
American Society of Interventional Pain Physicians News | August 10, 2016
|
|
|
Legislative Session and Capitol Hill Visits - Room Block Ends Friday
A legislative conference is scheduled for September 7 and 8. To participate in this conference, you must to be in Washington on Tuesday, September 6 in order to attend the 5 pm preparation session. We will have Capitol Hill visits and speeches, etc., on Wednesday morning and afternoon (Sept. 7). We will be preparing you for the presentation on Tuesday evening at 5:00 pm. We will be attending Capitol Hill with speeches in the morning of Wednesday and Capitol Hill visits with individual members of the Congress on Wednesday afternoon. Some appointments may continue through Thursday. If you would like to leave on Wednesday, please do not plan on leaving before 6 pm. If you want to stay, that would be wonderful as visits will continue on Thursday for those who are available to stay.
Each member is expected to visit two senators and one member of Congress for a total of three visits.
ASIPP will book and pay for your room at the Phoenix Park Hotel in Washington, DC. You will be responsible for your own travel expenses.
It is crucial that we have as many people as possible in attendance for this legislative conference. Please block your schedule as soon as possible so that you can attend.
While many of the members and committees are important, we are specifically focusing on the following senators and members.
Click here for the list.
Please let us know as soon as possible if you will be attending so that we can begin making the appointments. Contact Melinda Martin at
[email protected] to RSVP
|
This comprehensive four day Regenerative Medicine Review Course. will run August 18-21, 2016 in Las Vegas, Nevada at The Caesars Hotel and the state-of-the-art Oquendo Center.
These unique courses meets the continuing needs of interventionalists, based on input and needs assessment over the years and are cutting edge educational programs. It entails two days of didactic courses and two days of hands-on workshops covering various aspects of regenerative medicine. The first two days involve comprehensive review courses in regenerative medicine and hands-on with live models.
This two day course is an essential component for interventional pain physicians and provides education opportunities to assist you in providing high-quality, competent, safe, accessible, and cost-efficient services to your patients. The next two days will be a Cadaver Workshop fashioned to techniques of regenerative medicine.
|
This Hands-On Cadaver Workshop in Interventional Techniques, including online lectures will run August 20 through August 21, 2016 in Las Vegas, Nevada at Caesars Palace Las Vegas and the state-of-the-art Oquendo Center. These unique courses meets the continuing needs of interventionalists, based on input and needs assessment over the years and are cutting edge educational programs. It entails the equivalent of two days of online lectures and two days of hands-on workshops covering various interventional techniques.
The 2 day Cadaver Workshop involves comprehensive review of interventional techniques. This two day 2 day Cadaver Workshop is an essential component for interventional pain physicians and provides education opportunities to assist you in providing high-quality, competent, safe, accessible, and cost-efficient services to your patients. Online Lectures from a recent Interventional Techniques couse are supplied for viewing prior to the cadaver workshop and will be available indefinitely after the meeting.
The Cadaver Workshop is fashioned to accommodate training levels and capacity of participants. Physicians can choose from basic, intermediate, or ABIPP examination preparation course levels to mirror your needs and skill level. it registration
|
|
FEW SPOTS LEFT!
The ASIPP®Comprehensive Review Courses and Competency Examination in Controlled Substance Management and Practice Management will be held in Las Vegas, NV, on August 18-20, 2016. These unique courses meet the continuing needs of interventionalists, based on input and needs assessment over the years and are cutting edge educational programs. They entail two days of didactic courses and a competency examination. Only physicians on the track to meet ABIPP requirements may take the combined examination. Others may take the single examination. The Practice Management course is so beneficial to practices, both officebased and ASCs, that many physicians send their staff early to keep them current on the cutting edge aspects of practice management.
These intensive review courses are designed to present interventional pain management specialists and other health care providers an in-depth review of multiple areas of interventional pain management-the areas we were never taught, yet are crucial for our survival. In addition to the review course, the American Board of Interventional Pain Physicians (for physicians) and the American Association of Allied Pain Management Professionals (for non-physicians) offers the opportunity for examination in order for physicians to obtain competency certification to and non-physicians to obtain associate certificates in Controlled Substance Management and/or Practice Management. Only physicians on the ABIPP track wanting to fulfill the ABIPP requirements may take the combined examination.
|
Are You Ready for October 2016: Honeymoon is Coming to an End
Order Your Pocket Guide Today!
 October 1, 2016, is coming. Along with it comes the end of the honeymoon period for ICD-10-CM is also coming. It essentially means you have to get ready for proper coding for the upcoming years.
Starting October 1, 2016, you must have a specific diagnosis for each condition you treat and for each procedure you perform.
You don't need to hit the panic button; there is help for preparation. But you should act now!
You can be prepared for the challenges of ICD-10-CM by purchasing the most definitive ICD-10-CM resource for interventional pain physicians.
If you have not already purchased and reviewed the ICD-10-CM for Interventional Pain Management: A Practical Guide, a pocket guide which will fit nicely in your pocket, you should order it immediately, not only for yourself, but for your staff, electronic and hard copy versions.
This exhaustive guide for interventional pain physicians will assist you with numerous intricacies of coding for interventional pain management. If you are not immediately ordering this practice guide, answer the following questions:
1. If you perform caudal epidural injection and cervical interlaminar epidural injection in a cervical and lumbar post surgery syndrome patient, can you use the same code for both procedures and get paid?
2. Can you perform lumbar transforaminal epidural injections at L5 and S1 in a patient with lumbar radiculitis at L5 only?
3. Can you use disc herniation and radiculopathy codes in the same patient in the same region?
If you answer "yes" for any of the above questions, you urgently need to prepare yourself and review these guidance.
|
ABIPP Certification Made Simple
The American Board of Interventional Pain Physicians (ABIPP) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified. ABIPP is recognized in 11 states. Ten states have no statutes governing specialty boards. Approval is pending in remaining states.
ABIPP is a Specialty Board providing certifications in the following areas:
Board Certification in Interventional Pain Management
Either with ABMS pain medicine board certification or ABMS primary certification only
Competency Certification in:
* Interventional Pain Management
* Regenerative Medicine
* Controlled Substance Management
* Coding, Compliance, and Practice Management
* Fluoroscopic Interpretation and Radiological Safety
* Endoscopic Spinal Decompression
Click HERE to view Pathway to ABIPP Certification
|
On the Need to Integrate Pain Psychology Into Training Programs, Continuing Education
In response to a call for improved pain management training from the Institute of Medicine and the Oversight Committee for the NIH Health and Human Services National Pain Strategy, a task force assessed stakeholders' perspectives on pain psychology and outlined needed resources.
Chronic pain is estimated to affect over 100 million people in the US and is associated with an annual financial burden of up to $635 billion.
1
Though psychology has long been recognized as essential in alleviating the pain experience, and a sizable body of research has underscored the importance of psychological factors in pain management and outcomes, these interventions are often overlooked or minimally addressed.
2-4
|
Start Planning NOW! ASIPP to Begin Accepting Abstracts for 2017 Annual Meeting
Registration will be open for Abstract Submissions beginning August 10, 2016.
The American Society of Interventional Pain Physicians will hold its 19th Annual Meeting April 20-22 in Las Vegas at Caesar's Palace.
This year, we will be making significant changes to the Abstract and Poster Sessions. Anyone who submits their Abstract for consideration will be included in the electronic poster presentations. The posters are available to all meeting participants during all bring and meal times.
The Abstract Committee will select the top 25 for publication in Pain Physician and of those 10 will be selected for Abstract presentation and judging during the Annual Meeting. The top 3 will receive cash prizes.
|
Transcutaneous Electrical Nerve Stimulation Therapy for Low Back Pain
Bayer announced the launch of Aleve Direct Therapy, a drug-free, pain relief device. It is indicated for temporary pain relief associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities.
Aleve Direct Therapy utilizes transcutaneous electrical nerve stimulation (TENS) technology which is thought to work by blocking the body's pain signals and by releasing endorphins at the site of pain.
|
Illicit Use of Gabapentin on the Rise
New research has uncovered a troubling trend of gabapentin abuse among patients who are also using opioid pain medications.
The results of the study, which were presented at the 68
th
annual AACC Scientific Meeting & Clinical Lab Expo in Philadephia, are especially troubling since physicians don't often screen forgabapentin abuse since there is little risk of abuse or addiction when taken alone. However, when taken in conjunction with opioids, muscle relaxants, or anxiety medications, use of gabapentin may perpetuate a user's "high."
|
ASIPP Podcast July, 2016
 On the July ASIPP® Podcast, we'll be talking with ASIPP®'s current president, Dr. Aaron Calodney. Our news segment this time has a number of medical marijuana stories, as well as stories about depressed medical residents, a gene that holds the key to potential pain treatments, and more. Plus, how getting a tattoo could be the key to curing the common cold.
|
Arymo, Long-Acting Morphine, Wins FDA Advisors' Support
 A joint FDA advisory committee voted 18-to-1 in favor of approving extended-release morphine sulfate tablets (Arymo), and generally agreed that it had abuse-deterrent properties via the oral, nasal, and injectable routes.
The anesthetic and analgesic drug products advisory committee (AADPAC) and the drug safety and risk management advisory committee (DSaRM) voted that the morphine pill, developed by Egalet, was harder to abuse via the oral (16-to-3), nasal (18-to-1), and intravenous (18-to-1) routes of abuse.
|
Monitoring Opioid Use in Real-Time With Wearable Device
A wearable biosensor has been shown to detect consistent physiological patterns after opioid administration, which could eventually provide a new method of opioid monitoring.
The researchers enrolled 30 subjects who presented at an emergency department (ED) with a pain-related complaint.
1
Enrollment took place over 4 months. Each subject wore the Q biosensor (Affectiva) - a 4x5cm sensor secured with a Velcro band - before, during and after opioid analgesic administration.
|
Rates of Opioid Agonist Therapy Prescriptions for Medicare Patients Reflect Treatment Gap
Medicare patients comprise a segment of the population that is particularly affected by opioid use disorder, with rates of related hospitalization growing by 10% annually.
1
While the number of commercial insurance patients estimated to have a diagnosed opioid use disorder is just over 1 per 1000 patients, more than 6 of every 1000 Medicare patients have been diagnosed.
2
Although prevention efforts are important, treatment for patients who have already developed addiction is also needed. Buprenorphine-naloxone-or buprenorphine alone for pregnant patients-is the only type of opioid agonist therapy (OAT) that is covered by Medicare Part D for the treatment of opioid use disorder.
Clinical Pain Advisor |
|
|
|
|
|
State Society News
|
|
Physicians Wanted To view or post a job, please go to: http://jobs.asipp.org/home To receive a member discount for posting a job, use member code: 20Member |
|
|
